Azithromycin in Idiopathic Pulmonary Fibrosis

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 19, 2014

Primary Completion Date

August 16, 2019

Study Completion Date

August 16, 2019

Conditions
Idiopathic Pulmonary FibrosisCough
Interventions
DRUG

azithromycin

Azithromycin is a macrolide antibiotic. 500mg Azithromycin will be given p.o. 3 times a week for 3 months. Azithromycin will be compared to placebo.

DRUG

placebo

Placebo will be given 3 times a wek over a period of 3 months.

Trial Locations (4)

3010

University Hospital for Pulmonology, Bern

Unknown

Universitätsspital Basel, Basel

Kantonsspital St. Gallen, Sankt Gallen

Universitätsspital Zürich, Zurich

All Listed Sponsors
collaborator

University of Bern

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT02173145 - Azithromycin in Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter